Fibrosis: all 1,270 studies
Page 2 of 13. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.
- Exploration of a Novel Prognostic Prediction Model for Liver CirrhosisRecruitingNCT07031843
- Prehab and Creatine/Whey Supplementation in Frailty Among Patients With CirrhosisRecruitingNCT07029243Not applicable
- Development and Testing of a Patient-facing Educational Tool About Liver Cancer PreventionRecruitingNCT07010315
- Application of Bacterial DNA Quantitative Detection in Diagnosis of SBP in Cirrhosis: A Multi Center Diagnostic ExperimentEnrolling by invitationNCT06995846
- Exploring Clinical Characteristics of Liver Disease Patients Based on Digestive Metabolic Exhaled AirRecruitingNCT06968234
- Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver TransplantRecruitingNCT06950788
- Study of the Impact of HYPOglycaemia on Sarcopenia in CIRrhosisRecruitingNCT06948656
- Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort StudyRecruitingNCT06948565
- Effect of YAP1-inhibition in Surgical Wounds.Not yet recruitingNCT06944249Phase 1/2
- Bumetanide vs. Furosemide in CirrhosisRecruitingNCT06941415Phase 3
- Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney InjuryRecruitingNCT06937307Phase 2
- A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHRecruitingNCT06920043Phase 2
- Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)RecruitingNCT06912763Phase 2
- Impact of Nutritional Management on the Frailty of Patients Waiting for Liver Transplantation (Via the LFI Tool)RecruitingNCT06911619Not applicable
- Predictors of Spontaneous Bacterial Peritonitis Among Patients with CirrhosisNot yet recruitingNCT06884306
- Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic PatientsRecruitingNCT06881628Phase 4
- Optimized Remission in Alcohol-related Liver CirrhosisRecruitingNCT06866496Not applicable
- A Simple Breath Test to Detect Liver Cancer and Monitor Liver ConditionsRecruitingNCT06864195
- EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPGRecruitingNCT06863012Not applicable
- CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic UltrasoundRecruitingNCT06861075Not applicable
- AI-Assisted MRE for Intestinal Fibrosis in Crohn's DiseaseRecruitingNCT06858553
- cACLD in Patients With Alcohol Use Disorder in the Hospital Detoxification UnitEnrolling by invitationNCT06838468
- Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) PlacementRecruitingNCT06814990Not applicable
- Albumin Assisted Diuresis in Patients with Cirrhosis and AscitesRecruitingNCT06812390Phase 2
- A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With CirrhosisRecruitingNCT06808074Phase 4
- Mechanism of TIPS to Improve SarcopeniaRecruitingNCT06794853
- mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With CirrhosisRecruitingNCT06778317
- Statin and Beta Blocker Use in Patients With Decompensated CirrhosisRecruitingNCT06764966Phase 2
- Screening of Patients With Hepatic Fibrosis or Cirrhosis B and CRecruitingNCT06755632Not applicable
- Examining the Effects of Different Resistive Exercise Programs in Individuals With Compensated Liver CirrhosisNot yet recruitingNCT06749340Not applicable
- Non-invasive Methods for Predicting Decompensation of Chronic Liver DiseaseEnrolling by invitationNCT06741904
- The Microbial Impact on Intestinal Fibrosis and the Associated Immune Microenvironment in Crohn's DiseaseNot yet recruitingNCT06720961
- Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal HypertensionRecruitingNCT06687265Phase 2
- Utilizing of Physiological Parameters Predict the Prognosis of Cirrhotic Patients With Gastrointestinal BleedingRecruitingNCT06680583
- Early Ascitis Parencentesis in SBPNot yet recruitingNCT06679842Not applicable
- Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.RecruitingNCT06676813Not applicable
- A Clinical Study to Evaluate CUD005 Injection in Patients with Liver CirrhosisEnrolling by invitationNCT06671275Phase 1
- Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH PatientsRecruitingNCT06661655Not applicable
- Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver CancerRecruitingNCT06658782
- International Surveillance of Antimicrobial Resistance in Cirrhosis-Related InfectionsRecruitingNCT06634940
- Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With CirrhosisEnrolling by invitationNCT06624189
- Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)Not yet recruitingNCT06623084
- A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)RecruitingNCT06619561Phase 2
- Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot StudyRecruitingNCT06619106
- Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHBNot yet recruitingNCT06616103
- CF Organization of Care in the Era of Highly Effective Modulator.RecruitingNCT06599892
- Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-respondersRecruitingNCT06594783Phase 4
- The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European RegionRecruitingNCT06561529Not applicable
- Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological FactorsRecruitingNCT06549673
- Evaluation of Patient Care Support for Cirrhosis and/or Liver TransplantsRecruitingNCT06544863
- The Effect of Exercise Training on Quality of Life and Disease Progression in Fibrosing Interstitial Lung PatientsRecruitingNCT06527612Not applicable
- EUS-guided Response Assessment to NSBBRecruitingNCT06513195Not applicable
- Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)RecruitingNCT06494111Phase 2
- Microbiome Modulation With Prebiotics in PTSD and CirrhosisRecruitingNCT06464952Not applicable
- A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With CirrhosisRecruitingNCT06461208Phase 3
- Getting To Implementation: Improving Cancer Screening for VeteransEnrolling by invitationNCT06458998Not applicable
- hepatomiR cACLD StudyRecruitingNCT06432582
- Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic EncephalopathyRecruitingNCT06425380Not applicable
- A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHRecruitingNCT06419374Phase 3
- FAPI-74 PET/CT in Adults With FibrosisRecruitingNCT06413355Phase 1
- PET/MRI for Evaluation of EndometriosisEnrolling by invitationNCT06377553
- Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)RecruitingNCT06345547
- The Influence of Nutritional Factors on the Prognosis of Liver Cirrhosis Patients and the Exploration of Predictive ModelsRecruitingNCT06328517
- Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant.RecruitingNCT06327308Phase 1
- Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY DiseaseRecruitingNCT06325488
- A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)RecruitingNCT06318169Phase 3
- Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch ViscoelastographyRecruitingNCT06316869
- Intra-Hepatic Microbiota in Alcoholic HepatitisRecruitingNCT06307964
- Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular EctasiasRecruitingNCT06306963
- To Evaluate the Clinical Study of CUD005 Injection in Patients With CirrhosisEnrolling by invitationNCT06296095Phase 1
- Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and CirrhosisRecruitingNCT06277882Phase 4
- Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver CirrhosisRecruitingNCT06265272
- PET/MRI of Primary Sclerosing CholangitisNot yet recruitingNCT06252610
- Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.RecruitingNCT06252493
- Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and AgeingRecruitingNCT06210555
- 3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal HypertensionRecruitingNCT06205992
- Population-wide Research for HBV-related Liver Diseases in Maoming CityNot yet recruitingNCT06184347
- Real-World Validation of a Prognostic Prediction Model for Patients With Acute Exacerbations of Chronic Liver DiseaseNot yet recruitingNCT06181448
- Subcutaneous Semaglutide in Systemic SclerodermaRecruitingNCT06149260Phase 1
- Comparison of the Effect of Two Interventions on Liver Frailty Index in Pre-frail and Frail Cirrhotic Patients Enlisted for Liver TransplantationRecruitingNCT06149026Not applicable
- Study on MAFLD-related Cirrhosis Prevention and Treatment StrategiesNot yet recruitingNCT06135584Not applicable
- Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]RecruitingNCT06125743Not applicable
- Oral Branched-chain Amino Acid Supplementation for Cirrhotic Patients With SarcopeniaEnrolling by invitationNCT06121492Phase 3
- Effectiveness of Ultrasound in Liver Stiffness and Fat QuantificationRecruitingNCT06111859Not applicable
- Project OASIS: Optimizing Approaches to Select Implementation StrategiesEnrolling by invitationNCT06061328Not applicable
- A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric PatientsNot yet recruitingNCT06021860Phase 4
- Alterations in Coagulation Factor Levels in Patients With End Stage Liver DiseaseNot yet recruitingNCT06014320
- A Prospective Study of Memantine in Patients With Cirrhosis and Liver CancerRecruitingNCT06007846Phase 2/3
- Dose-Escalation Study of Artesunate Patients With IPFRecruitingNCT05988463Phase 1
- Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisRecruitingNCT05975983Phase 2
- CirrhosisRx CDS SystemRecruitingNCT05967273Not applicable
- Novel Cellular Therapy for the Treatment of Pain Associated With Chronic PancreatitisRecruitingNCT05925036Phase 1
- CMR in T2DM: The NSR CohortEnrolling by invitationNCT05915260
- Diaphragmatic Function as a BiomarkerRecruitingNCT05903001
- Precision Medicine to Predict the Trajectory of Liver Cirrhosis: Prospective Cohort StudyRecruitingNCT05899309
- Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)RecruitingNCT05892614Phase 2
- Evaluation of the Medical Benefit of Spa Therapy on Fibrosis After Radiotherapy for Breast Cancer or UADT (Upper Aerodigestive Tract) CancerRecruitingNCT05874492Not applicable
- DOAC in Patients with Child a or B Liver CirrhosisRecruitingNCT05869591Phase 2
- Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesRecruitingNCT05832229Phase 2
- A Non-invasive Diagnostic Model for Intestinal Fibrosis in Crohn's Disease Based on 18F-FAPI PET ImagingRecruitingNCT05824962